[1]
Đào Thanh, M. et al. 2025. ASSESSMENT OF OUTCOMES OF FIRST-LINE GEFITINIB TREATMENT FOR STAGE IV NON-SMALL CELL LUNG CANCER AT HANOI MEDICAL UNIVERSITY HOSPITAL. Vietnam Medical Journal. 554, 2 (Oct. 2025). DOI:https://doi.org/10.51298/vmj.v554i2.15655.